School of Medicine
Showing 4,221-4,240 of 7,139 Results
Rachel L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Neurology
Current Research and Scholarly Interests EXPERIMENTAL, CLINICAL AND THEORETICAL SYSTEMS NEUROSCIENCE
Cognitive neuroscience; Systems neuroscience; Cognitive development; Psychiatric neuroscience; Functional brain imaging; Dynamical basis of brain function; Nonlinear dynamics of neural systems.
Mark Mercola, PhD
Professor of Medicine (Cardiovascular)
Bio Dr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.
Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury.
He established drug screening and assay development at the Conrad Prebys Center for Chemical Genomics, which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers. He co-founded two companies, ChemRegen, Inc., a start-up dedicated to developing small molecules for stem cell and cancer applications, and EpikaBio, Inc., dedicated to developing a device for myocardial regeneration.
Prof. Mercola received an NIH MERIT award for his work on heart formation, and authored over 120 papers. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences (San Diego), Stem Cell Theranostics (Palo Alto) and the Human Biomolecular Research Institute (San Diego). His laboratory is funded by the NIH, California Institute for Regenerative Medicine and the Fondation Leducq.
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly Interests I am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
Jason D. Merker, MD, PhD
Assistant Professor of Pathology at the Stanford University Medical Center
Bio Dr. Merker is a clinical laboratory-based physician who specializes in genetic disease testing for both heritable disease and cancer. He is board-certified in Molecular Genetic Pathology, Clinical Pathology, and Clinical Cytogenetics. Dr. Merker is Co-Director of the Stanford Medicine Clinical Genomics Service, a laboratory section within the Stanford Anatomic Pathology & Clinical Laboratories that uses genomic sequencing and other advanced methods to evaluate the cause of disease in patients with unexplained heritable disease. He also directs an active research group that focuses on two areas: 1) development of improved experimental and computational approaches related to the use of genomic sequencing and other “omics” assays for clinical care, and 2) identification and characterization of acquired and heritable genetic variants that are important for the development of hematologic disorders and other malignancies.
Anna H. Messner, M.D.
Professor of Otolaryngology-Head and Neck Surgery and of Pediatrics at the Stanford University Medical Center and the Lucile Salter Packard Children's Hospital
Current Research and Scholarly Interests -- Obstructive sleep apnea in children
-- Postoperative tonsillectomy care
-- Medical Education
Instructor, Cardiovascular Institute
Current Research and Scholarly Interests Development, maintenance, and repair of the pulmonary circulation
Everett Meyer, M.D., Ph.D.
Assistant Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
Current Research and Scholarly Interests Research focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.
Jessica Patricia Meyer
Research Education & Events Coordinator, SPECTRUM (CTSA/SCCTR)
Current Role at Stanford Spectrum Operations, Training and Compliance is part of Spectrum, the CTSA-funded Stanford Center for Clinical and Translational Education and Research.
In her role as education coordinator/ event planner, she coordinates various education and training events, facilitates the Spectrum KL2/TL1 application process, and manages program communications. Other facets include supporting regulatory services and process improvement.
- Intensive Course in Clinical Research: Study Design and Performance for new investigators interested in clinical and translational research careers at Stanford.
- Stanford K-Fest
- Stanford Education Planning Initiative (SEPI) monthly workshops
- Translational Medicine 3-day Course
Stanford University Professor of Nephrology
Current Research and Scholarly Interests Inadequate removal of uremic solutes contributes to widespread illness in the more than 350,000 Americans maintained on hemodialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.
Mrs. George A. Winzer Professor in Cell Biology
Current Research and Scholarly Interests CELLULAR INFORMATION PROCESSING The main problem in signal transduction is to understand how different receptor-stimuli specifically control diverse cell functions. We are using automated microscopy, live-cell fluorescent biosensors and perturbations of predicted signaling proteins to systematically dissect signaling networks. This allows us to identify signaling modules and to elucidate and ultimately model the flow of cellular information.